ADC Therapeutics SA (ADCT) Revenue 2022–2025
ADC Therapeutics SA (ADCT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$81.4MFY2025 · since FY2022: $74.9M → $81.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81.4M | +14.9% |
| FY2024 | $70.8M | +2.6% |
| FY2023 | $69.1M | -7.8% |
| FY2022 | $74.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADCT financial trends
ADCT Net incomeADCT Net marginADCT Gross profitADCT Gross marginADCT Operating incomeADCT Operating marginADCT Operating cash flowADCT Free cash flowADCT Capital expendituresADCT Return on equityADCT Stock buybacksADCT Dividends paidADCT Total assetsADCT Total liabilitiesADCT Shareholders’ equityADCT overview →